Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19

Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19

Coronavirus disease 2019 (COVID-19) has caused significant devastation globally. Despite the development of several vaccines, with uncertainty around global uptake and vaccine efficacy, the need for effective therapeutic agents remains. Increased levels of cytokines including tumour necrosis factor...

Full description

Bibliographic Details
Main Authors: Serena Patel, Meenu Wadhwa
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Biomedicine & Pharmacotherapy
Subjects:
COVID-19
Tumour necrosis factor (TNF)
Cytokines
International standards
Clinical trials
Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221005679

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221005679

Similar Items